Your Article Summary
A myeloproliferative disorder may hide another one
Leukemia Research, 06/19/09
Laibe S et al. - The authors raise the problem of a CML developing on an initial IMF, or two MPDs occurring from a common or two different stem cells.
Related Articles
Chronic idiopathic myelofibrosis with myeloid metaplasia presenting as refractory ascites
Pediatric Blood & Cancer, 10/19/09
Relevance Score: 64%
Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia
British Journal of Haematology, 10/05/09
Relevance Score: 64%
Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera
Cancer, 10/08/09
Relevance Score: 63%
The association between arthritis and psychiatric disorders; results from a longitudinal population-based study
Journal of Psychosomatic Research, 10/12/09
Relevance Score: 47%
Clinical management of motility disorders in children
Seminars in Pediatric Surgery, 10/01/09
Relevance Score: 47%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell–fibronectin adhesion of colon cancer cells
Oncogene, 11/25/09
A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
Oncogene, 11/25/09
Embryoid body formation of human amniotic fluid stem cells depends on mTOR
Oncogene, 11/25/09
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
Oncogene, 11/25/09
International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis
Blood, 11/25/09
Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation
Experimental Hematology, 11/25/09

See Latest Articles